Insilico Medicine Unveils Innovative CDK12/13 Dual Inhibitors for Tumor Therapy with the Help of Generative AI
Insilico Medicine, a pioneering biotechnology company specializing in generative artificial intelligence (AI), has recently made significant strides in cancer treatment. ...
